BE879494A - Procede de production de l'oxymorphone - Google Patents

Procede de production de l'oxymorphone

Info

Publication number
BE879494A
BE879494A BE0/197710A BE197710A BE879494A BE 879494 A BE879494 A BE 879494A BE 0/197710 A BE0/197710 A BE 0/197710A BE 197710 A BE197710 A BE 197710A BE 879494 A BE879494 A BE 879494A
Authority
BE
Belgium
Prior art keywords
oxymorphone
production process
production
oxymorphone production
Prior art date
Application number
BE0/197710A
Other languages
English (en)
French (fr)
Inventor
M Wilson
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of BE879494A publication Critical patent/BE879494A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polarising Elements (AREA)
BE0/197710A 1978-10-19 1979-10-18 Procede de production de l'oxymorphone BE879494A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95305678A 1978-10-19 1978-10-19

Publications (1)

Publication Number Publication Date
BE879494A true BE879494A (fr) 1980-02-15

Family

ID=25493512

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/197710A BE879494A (fr) 1978-10-19 1979-10-18 Procede de production de l'oxymorphone

Country Status (16)

Country Link
JP (1) JPS55501025A (cs)
AU (1) AU5189779A (cs)
BE (1) BE879494A (cs)
CA (1) CA1108132A (cs)
CS (1) CS211364B2 (cs)
DK (1) DK258280A (cs)
ES (1) ES485154A1 (cs)
FI (1) FI793235A7 (cs)
FR (1) FR2439201A1 (cs)
GB (1) GB2049680A (cs)
IL (1) IL58489A0 (cs)
IT (1) IT7969032A0 (cs)
NL (1) NL7920126A (cs)
NO (1) NO793297L (cs)
SE (1) SE8004454L (cs)
WO (1) WO1980000841A1 (cs)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795813A (en) * 1981-08-17 1989-01-03 The Florida Board Of Regents On Behalf Of The Florida State University Synthesis of derivatives of codeine and other 3-O-alkylmorphines
US5668285A (en) * 1986-10-31 1997-09-16 The United States Of America As Represented By The Department Of Health And Human Services Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
FR2636330B1 (fr) * 1988-09-13 1990-11-30 Sanofi Sa Procede de preparation de derives de morphinane
CA2067200C (en) * 1989-10-16 1998-06-30 Kenner C. Rice Total synthesis of northebaine, normorphine, noroxymorphone enantiomers and derivatives via n-nor intermediates
DE60223254T2 (de) 2001-07-06 2008-08-14 Penwest Pharmaceuticals Co. Verzögert freisetzende formulierungen von oxymorphon
JP2005515966A (ja) 2001-07-06 2005-06-02 エンドー ファーマシューティカルズ, インコーポレイティド 鎮痛薬としての使用のための6−ヒドロキシ−オキシモルホンの経口投与
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
CN101395159A (zh) 2006-03-02 2009-03-25 马林克罗特公司 制备含有低含量α,β-不饱和酮化合物的吗啡烷-6-酮产物的方法
CA2713128C (en) 2008-01-25 2016-04-05 Gruenenthal Gmbh Pharmaceutical dosage form
AU2009243681B2 (en) 2008-05-09 2013-12-19 Grunenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
CN102639118B (zh) 2009-07-22 2015-07-29 格吕伦塔尔有限公司 氧化稳定的抗干扰剂型
KR101738369B1 (ko) 2009-07-22 2017-05-22 그뤼넨탈 게엠베하 핫 멜트 압출된 제어 방출 투여형
TWI516286B (zh) 2010-09-02 2016-01-11 歌林達股份有限公司 含陰離子聚合物之抗破碎劑型
BR112013005194A2 (pt) 2010-09-02 2016-05-03 Gruenenthal Gmbh forma de dosagem resistente à violação compreendendo sal inorgânico
BR112014001091A2 (pt) 2011-07-29 2017-02-14 Gruenenthal Gmbh comprimido resistente à adulteração que fornece liberação imediata do fármaco
EA201400172A1 (ru) 2011-07-29 2014-06-30 Грюненталь Гмбх Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
MX356421B (es) 2012-02-28 2018-05-29 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
EP2838512B1 (en) 2012-04-18 2018-08-22 Grünenthal GmbH Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US9737490B2 (en) 2013-05-29 2017-08-22 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
EP3003279A1 (en) 2013-05-29 2016-04-13 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles
BR112016000194A8 (pt) 2013-07-12 2019-12-31 Gruenenthal Gmbh forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila
EP3073994A1 (en) 2013-11-26 2016-10-05 Grünenthal GmbH Preparation of a powdery pharmaceutical composition by means of cryo-milling
WO2015173195A1 (en) 2014-05-12 2015-11-19 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
EA201692388A1 (ru) 2014-05-26 2017-05-31 Грюненталь Гмбх Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
WO2016170097A1 (en) 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
EP3252055B1 (en) 2016-05-31 2018-09-19 Alcaliber Investigacion Desarrollo e Innovacion SLU Process for obtaining 3,14-diacetyloxymorphone from oripavine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249616A (en) * 1966-05-03 Ix-dfflydroxy-g-oxo-n-phenethylmor- phinan (cis) and production thereof
US2806033A (en) * 1955-08-03 1957-09-10 Lewenstein Morphine derivative
US3775414A (en) * 1972-05-10 1973-11-27 Bristol Myers Co Process for the preparation of 14-hydroxymorphinan derivatives

Also Published As

Publication number Publication date
ES485154A1 (es) 1980-06-16
GB2049680A (en) 1980-12-31
NL7920126A (nl) 1980-08-29
NO793297L (no) 1980-04-22
IL58489A0 (en) 1980-01-31
JPS55501025A (cs) 1980-11-27
FI793235A7 (fi) 1981-01-01
WO1980000841A1 (en) 1980-05-01
CS211364B2 (en) 1982-02-26
CA1108132A (en) 1981-09-01
AU5189779A (en) 1980-04-24
IT7969032A0 (it) 1979-10-18
FR2439201A1 (fr) 1980-05-16
SE8004454L (sv) 1980-06-16
DK258280A (da) 1980-06-17

Similar Documents

Publication Publication Date Title
BE879494A (fr) Procede de production de l'oxymorphone
FR2414263B1 (fr) Procede de branchement
FR2439813B1 (fr) Procede de deparaffinag
BE878902A (fr) Procede de production d'alkylene-glycols
FR2342981A1 (fr) Procede de preparation d'hydrogenosilanes
FR2434780B1 (fr) Procede de production d'ammoniac
BE863808A (fr) Procede de production de l'acide 5-methyltetrahydrofoliquded
BE873456A (fr) Procede d'assemblage de moules
PT69815A (fr) Procede de preparation de l' o-methallyloxyphenol
BE878235A (fr) Procede de clivage de dihydroxydiphenylalcanes
BE875378A (fr) Procede de preparation d'alcoylsilanes
BE885672A (fr) Procede de production d'electrode
BE875844A (fr) Procede de production de cephalosporines
BE878234A (fr) Procede de preparation d'isopropenylphenol
PT70408A (fr) Procede d'obtention de noveaux aryltrifluoroethanols
FR2342337A1 (fr) Procede de production d'ubiquinone-10''
BE852148A (fr) Procede de production d'hydrazobenzenes
PT69545A (fr) Procede d'oxyhydrochloration non polluant
FR2438640B1 (fr) Procede de production de monoalcoyl-aromatiques
BE873855A (fr) Procede de production du monordene
IT1207017B (it) Procedimento per la produzione di metil-nonil-acetaldeide
BE871961A (fr) Procede ameliore pour la production d'alkylene-glycols
BE857485A (fr) Procede de production d'hecachlorocyclopentadiene
FR2422671B1 (fr) Procede pour l'obtention d'ethylsilanes
BE863343A (fr) Procede de production d'ethylene-thiouree